linkedin

Press Releases

Samsung BIO Insight

CPhI Worldwide 2021 I Infinite Possibilities for the Next Decade

CPhI Worldwide 2021 I Infinite Possibilities for the Next Decade 

 

Previously held virtual due to the ongoing pandemic, CPhI Worldwide this year took place at Fiera Milano, Italy from November 9th to 11th and our team of experts attended in-person to engage and interact with the industry leaders including our clients.

 

CPhI Worldwide is a professional gathering of exhibitors with sessions geared towards various aspects of the active ingredients, contract services, medical devices, and packaging. The event hosted more than 2,500 companies with more than 48,000 pharma industry peers in attendance, providing an industry-leading setting to seek business opportunities, share insights, and source technical solutions all under one roof.

 

 

Connecting with industry leaders


Samsung Biologics welcomed industry peers at its independent booth, themed 'Infinite Possibilities for the Next Decade', showcasing its new service offerings as well as future plans. A panoramic display highlighted key capabilities of Samsung Biologics as an end-to-end CDMO with 'world's largest manufacturing capacity of 620,000L', 'S-CellerateTM (CDO process platform to expedite timeline to IND and BLA)', and 'Multi-modality expansion'. 

 

1.%20GIMC_??%20???.jpg
 

2.%20CPhI_211109_004_L.jpg
 

3.%20CPhI_211109_029_L.jpg
 

4.%20CPhI_211109_002_L.jpg
 

James Choi, Senior Vice President and Chief Information and Marketing Officer, Head of Investor Relations said, “A large number of people came to visit us at our booth despite the ongoing pandemic and it was great to be back to connect with the clients and industry leaders in person. I believe the event zone and VR zone provided special and memorable experience to the visitors, and there were also great deal of active engagement and business discussions.  Doing so, we showcased our fully integrated, end-to-end services of CDO, CMO, and biosafety testing services with top-notch quality which will help our clients to bring their life-saving drugs to the patients."

 

5.%20CPhI_211109_008_L.jpg
 

6..jpg
  

7.%20CPhI_211109_003_M.jpg
 

“Samsung Biologics' booth was designed to highlight its core brand identity that was newly established earlier this year. To better conduct meetings with clients and industry stakeholders, we provided three meeting rooms and an open lounge area for us to network and connect more efficiently. Also, most importantly, we took precautionary measures in regards to COVID-19 before and after meetings to ensure the safety of both our employees and visitors during the event," added Dahyun, a Senior Specialist on the Digital Marketing Team.

 


Serving the needs of clients in person, in real-time


Samsung Biologics hosted active in-person meetings and explored various business opportunities with potential clients who were seeking development & manufacturing services for their drug portfolios.

 

"This was an important event for Samsung Biologics as it was the first large on-site exhibition since the COVID-19 pandemic to engage with global clients in person. We met with a large number of clients from all over the world and were able to demonstrate our services and capabilities, advancing it to in-depth business discussions for future projects," Donghyun Kim, a Lead Specialist on the Sales Team, stated. 

 

8.%20CPhI_211109_021_L.jpg
 

9.%20CPhI_211109_023_L.jpg
 

Haeun Yu, a Senior Specialist on the Sales Team, added, “We introduced some of our recent milestones, such as our ability to offer multi-modalities including mRNA, the launch of our new CDO process platform S-CellerateTM and our own proprietary cell line S-CHOice®, and Plant 4, to-be the world's largest biomanufacturing facility to date. We had visitors tell us that they came to this year's CPhI Worldwide just to meet with us and it was amazing to see the increasing worldwide interest and demand for Samsung Biologics' service offerings."

  


‘Driven. For Life.'


At CPhI Worldwide 2021, Samsung Biologics also introduced its new corporate advertising/branding video as a preview to the visitors, especially featuring its business purpose of ‘Driven. For Life.’ as well as its key attributes of speed, quality, and innovation DNA.

 

10.jpg
 

- 'It’s in our DNA', 'What are you driven. for?' episodes represent the company's work to save the lives of people around the world.

- 'Together, We' series comprises of three episodes - 'Speed', 'Quality', 'Innovation' - which represent the core values that Samsung Biologics stands for. 

 

 

Maximizing client satisfaction and saving patients' lives


Samsung Biologics would like to thank everyone who connected with us at this year's CPhI Worldwide, whether you visited the booth or networked at the reception. Orhan Caglayan, Brand Director of Informa Markets, the organizing body of CPhI Worldwide shared his views on this year's event during an interview with Samsung Biologics.  

 

11.%20Orhan%20Caglayan%20Brand%20Director.jpg
 

“For the past thirty years, CPhI was a setting for industry leaders to discuss the innovation of the biopharmaceutical industry. By far, this year is probably the year where we were all able to witness in person how biologics is now the future of the pharmaceutical industry and Samsung Biologics is at the forefront of this shift.

Samsung Biologics has always been our partner and I want to express my sincere gratitude to you for participating in this global event despite the COVID-19 pandemic," Orhan Caglayan said.

 13.jpg

 

14_Final.jpg
 

Samsung Biologics will continue to pursue innovation in every area, while ensuring speed and quality to ultimately create a better future for humanity.

 

 

Driven. For Life.


 

Related contents


News Brief Samsung Biologics participates in CPhI Worldwide 2021

BIO Insight Talking COVID-19 Vaccine Cooperation with John Rim

 

 

CPhI Worldwide 2021 I Infinite Possibilities for the Next Decade 

 

Previously held virtual due to the ongoing pandemic, CPhI Worldwide this year took place at Fiera Milano, Italy from November 9th to 11th and our team of experts attended in-person to engage and interact with the industry leaders including our clients.

 

CPhI Worldwide is a professional gathering of exhibitors with sessions geared towards various aspects of the active ingredients, contract services, medical devices, and packaging. The event hosted more than 2,500 companies with more than 48,000 pharma industry peers in attendance, providing an industry-leading setting to seek business opportunities, share insights, and source technical solutions all under one roof.

 

 

Connecting with industry leaders


Samsung Biologics welcomed industry peers at its independent booth, themed 'Infinite Possibilities for the Next Decade', showcasing its new service offerings as well as future plans. A panoramic display highlighted key capabilities of Samsung Biologics as an end-to-end CDMO with 'world's largest manufacturing capacity of 620,000L', 'S-CellerateTM (CDO process platform to expedite timeline to IND and BLA)', and 'Multi-modality expansion'. 

 

1.%20GIMC_??%20???.jpg
 

2.%20CPhI_211109_004_L.jpg
 

3.%20CPhI_211109_029_L.jpg
 

4.%20CPhI_211109_002_L.jpg
 

James Choi, Senior Vice President and Chief Information and Marketing Officer, Head of Investor Relations said, “A large number of people came to visit us at our booth despite the ongoing pandemic and it was great to be back to connect with the clients and industry leaders in person. I believe the event zone and VR zone provided special and memorable experience to the visitors, and there were also great deal of active engagement and business discussions.  Doing so, we showcased our fully integrated, end-to-end services of CDO, CMO, and biosafety testing services with top-notch quality which will help our clients to bring their life-saving drugs to the patients."

 

5.%20CPhI_211109_008_L.jpg
 

6..jpg
  

7.%20CPhI_211109_003_M.jpg
 

“Samsung Biologics' booth was designed to highlight its core brand identity that was newly established earlier this year. To better conduct meetings with clients and industry stakeholders, we provided three meeting rooms and an open lounge area for us to network and connect more efficiently. Also, most importantly, we took precautionary measures in regards to COVID-19 before and after meetings to ensure the safety of both our employees and visitors during the event," added Dahyun, a Senior Specialist on the Digital Marketing Team.

 


Serving the needs of clients in person, in real-time


Samsung Biologics hosted active in-person meetings and explored various business opportunities with potential clients who were seeking development & manufacturing services for their drug portfolios.

 

"This was an important event for Samsung Biologics as it was the first large on-site exhibition since the COVID-19 pandemic to engage with global clients in person. We met with a large number of clients from all over the world and were able to demonstrate our services and capabilities, advancing it to in-depth business discussions for future projects," Donghyun Kim, a Lead Specialist on the Sales Team, stated. 

 

8.%20CPhI_211109_021_L.jpg
 

9.%20CPhI_211109_023_L.jpg
 

Haeun Yu, a Senior Specialist on the Sales Team, added, “We introduced some of our recent milestones, such as our ability to offer multi-modalities including mRNA, the launch of our new CDO process platform S-CellerateTM and our own proprietary cell line S-CHOice®, and Plant 4, to-be the world's largest biomanufacturing facility to date. We had visitors tell us that they came to this year's CPhI Worldwide just to meet with us and it was amazing to see the increasing worldwide interest and demand for Samsung Biologics' service offerings."

  


‘Driven. For Life.'


At CPhI Worldwide 2021, Samsung Biologics also introduced its new corporate advertising/branding video as a preview to the visitors, especially featuring its business purpose of ‘Driven. For Life.’ as well as its key attributes of speed, quality, and innovation DNA.

 

10.jpg
 

- 'It’s in our DNA', 'What are you driven. for?' episodes represent the company's work to save the lives of people around the world.

- 'Together, We' series comprises of three episodes - 'Speed', 'Quality', 'Innovation' - which represent the core values that Samsung Biologics stands for. 

 

 

Maximizing client satisfaction and saving patients' lives


Samsung Biologics would like to thank everyone who connected with us at this year's CPhI Worldwide, whether you visited the booth or networked at the reception. Orhan Caglayan, Brand Director of Informa Markets, the organizing body of CPhI Worldwide shared his views on this year's event during an interview with Samsung Biologics.  

 

11.%20Orhan%20Caglayan%20Brand%20Director.jpg
 

“For the past thirty years, CPhI was a setting for industry leaders to discuss the innovation of the biopharmaceutical industry. By far, this year is probably the year where we were all able to witness in person how biologics is now the future of the pharmaceutical industry and Samsung Biologics is at the forefront of this shift.

Samsung Biologics has always been our partner and I want to express my sincere gratitude to you for participating in this global event despite the COVID-19 pandemic," Orhan Caglayan said.

 13.jpg

 

14_Final.jpg
 

Samsung Biologics will continue to pursue innovation in every area, while ensuring speed and quality to ultimately create a better future for humanity.

 

 

Driven. For Life.


 

Related contents


News Brief Samsung Biologics participates in CPhI Worldwide 2021

BIO Insight Talking COVID-19 Vaccine Cooperation with John Rim

 

 

SITE MAP

close
Close

Thank you for Subscribing to Our Newsletter

아래 다운로드 버튼을 클릭하시면 바로 다운로드 하실 수 있습니다.

Close

Subscribe to Our Newsletter

파일 다운로드를 위해 뉴스레터 구독용 이메일 주소를 입력해주세요.
* 구독자라면 구독중인 이메일 주소를 입력해주세요.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

뉴스레터 구독 서비스를 등록하시면 당사 뉴스룸에서 제공되는
삼성바이오로직스의 최신 소식과 관심 분야별 유용한 정보를 받아 보실 수 있습니다.

Subscribe to Our Newsletter
    • - 개인정보 수집 목적 : 이메일 발신서비스 제공
    • - 개인정보 수집 항목 : 이메일 주소, 회사명, 이름, 직급, 국가
    • - 이용 및 보관 기간 : 이메일 발신서비스 해지 시까지

    개인정보 수집에 동의하지 않을 시, 뉴스레터 서비스를 이용할 수 없습니다.

    삼성바이오로직스 개인정보 보호정책에 따라 개인정보는 안전하게 관리됩니다.

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved